The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Pfizer Inc shares valued at $1,312,736 were purchased by Dolsten Mikael on May 05 ’25. At $23.87 per share, Dolsten Mikael acquired 55,000 shares.
Also, DAMICO JENNIFER B. sold 2,500 shares, netting a total of over 64,825 in proceeds. Following the sale of shares at $25.93 each, the insider now holds 11,850 shares.
Before that, BLAYLOCK RONALD E had added 19,457 shares to its account. In a trade valued at $499,072, the Director bought Pfizer Inc shares for $25.65 each. Upon closing the transaction, the insider’s holdings increased to 19,457 shares, worth approximately $0.61 million.
As published in their initiating research note from Cantor Fitzgerald on April 22, 2025, Pfizer Inc [PFE] has been a Neutral and the price target has been revised to $24. As of November 15, 2024, Wolfe Research has initiated its “an Underperform” rating for PFE.
Analyzing PFE Stock Performance
During the last five days, there has been a drop of approximately -3.38%. Over the course of the year, Pfizer Inc shares have dropped approximately -17.00%. Shares of the company reached a 52-week high of $27.57 on 01/07/25 and a 52-week low of $20.92 on 04/09/25. A 50-day SMA is recorded $24.05, while a 200-day SMA reached $26.66.
Support And Resistance Levels for Pfizer Inc (PFE)
According to the 24-hour chart, there is a support level at 21.69, which, if violated, would cause prices to drop to 21.37. In the upper region, resistance lies at 22.62. The next price resistance is at 23.23. RSI (Relative Strength Index) is 39.63 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.56, which suggests the price will decrease in the coming days. Percent R is at 97.98%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
